A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and similar GLP-1 agonists, but without muscles loss as a potential side-effect. This is the conclusion of a new study by an international team of researchers led from the biotech firm Atrogi AB.

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.

Lizzo revealed on the 'Just Trish' podcast on June 19 that she has tried Ozempic and other GLP-1 drugs — which are medications that have become popular with celebrities due to their appetite-regulating effects — but that she no longer uses them and instead utilizes a 'mind-over-matter' approach.